XML 55 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Revenue    
Total revenue $ 16,378 $ 17,924
Costs and expenses    
Cost of goods sold 89,798 153,260
Research and development expenses 18,708 18,469
Selling, general and administrative expenses 53,650 60,623
Loss from write-down of property, plant and equipment 7,159 6,846
Grant income, net 0 (16)
Total costs and expenses 169,315 239,182
Operating loss (152,937) (221,258)
Other (expense) income    
Change in fair value of warrants (24,980) 848
Change in fair value of derivatives - related parties 9,983 10,880
Loss on debt extinguishment (3,510) (942)
Other expense (1,795) (477)
Loss before income taxes (229,475) (229,762)
Income tax expense 31 51
Net loss (229,506) (229,813)
Other comprehensive income    
Foreign currency translation adjustment, net of tax 1 6
Comprehensive loss $ (229,505) $ (229,807)
Basic and diluted loss per share attributable to common shareholders    
Basic (in usd per share) $ (1.81) $ (3.68)
Diluted (in usd per share) $ (1.81) $ (3.68)
Weighted average shares of common stock    
Basic (in shares) 126,967,756 62,439,857
Diluted (in shares) 126,967,756 62,439,857
Nonrelated Party    
Other (expense) income    
Interest expense, net $ (18,770) $ (7,915)
Related Party    
Other (expense) income    
Interest expense, net $ (37,466) $ (10,898)